Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation.

Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Lung Cancer Pubmed

Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation.

Loading next page...
 
/lp/pubmed/promising-efficacy-of-sorafenib-in-a-relapsed-thymic-carcinoma-with-c-97Pk6kqD7K

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0169-5002
DOI
10.1016/j.lungcan.2010.09.011
pmid
20970876

Abstract

Journal

Lung CancerPubmed

Published: Mar 28, 2011

There are no references for this article.